Given there is now community transmission of Omicron in Britain, the British government will remove all 11 nations off its COVID-19 travel red list as
Category: Health
Moderna CEO says COVID shots are weaker against Omicron, leading to the market crash.
On Tuesday, the CEO of drugmaker Moderna raised new concerns in financial markets by stating that existing COVID-19 vaccinations will be less effective against the
WHO puts the world on red alert over Omicron and needs for the global accord to fight pandemics.
The World Health Organization (WHO) said on Monday that the extensively mutated Omicron coronavirus strain is likely to spread internationally and poses a very high
Repurchase of Novartis’ $20.7b shareholdings approved by Roche shareholders
Roche shareholders overwhelmingly approved the $20.7 billion agreement to buy Novartis’ approximately one-third voting stock on Friday, according to the Swiss drugmaker. Roche held an
Pfizer’s COVID vaccine for children aged 5 to 11 has been approved by an EU authority.
The European Union’s pharmaceuticals regulator approved Pfizer’s coronavirus vaccine for use on children aged 5 to 11 years old on Thursday, paving the way for
Poor countries face shortages of covid vaccines after first jab.
Upwards of 60 nations, including a portion of the worlds most unfortunate may be slowed down at the primary shots of their Covid vaccines in
Resistance develops against UK vaccine passports
Over 70 British legislators have flagged their resistance to the presentation of purported vaccine IDs that the government is thinking about getting to assist with
AstraZeneca blamed for carefully selecting Vaccine study data
AstraZeneca may have included “obsolete data” in promoting the adequacy of its Coronavirus immunization in a U.S. study, federal health authorities said Tuesday in an
AstraZeneca: US data shows vaccine effective for all grown-ups.
AstraZeneca revealed Monday that its Coronavirus antibody gave solid insurance among all grown-ups in an expected U.S. study, raising expectations that the discoveries could help
Roche agrees to buy GenMark Diagnostics in $1.8 billion deal
Roche will purchase GenMark Diagnostics, a U.S.- based producer of molecular diagnostic tests in a $1.8 billion arrangement, the Swiss drugs producer said on Monday.
Load More
